| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/25/2023 | 62.6% | Stifel | $9 → $6 | Maintains | Buy |
| 05/12/2023 | 116.8% | Craig-Hallum | $14 → $8 | Maintains | Buy |
| 11/16/2022 | 103.25% | Alliance Global Partners | $9.15 → $7.5 | Maintains | Buy |
| 08/18/2022 | 306.5% | Aegis Capital | $20 → $15 | Maintains | Buy |
| 08/16/2022 | 279.4% | Cowen & Co. | $18 → $14 | Maintains | Outperform |
| 05/16/2022 | 442.01% | Aegis Capital | $23 → $20 | Maintains | Buy |
| 05/16/2022 | 387.8% | Cowen & Co. | $14 → $18 | Maintains | Outperform |
| 05/13/2022 | — | Alliance Global Partners | Upgrades | Neutral → Buy | |
| 01/26/2022 | 577.51% | Aegis Capital | $28 → $25 | Maintains | Buy |
| 08/19/2021 | 658.81% | Aegis Capital | $35 → $28 | Maintains | Buy |
| 04/22/2021 | 740.11% | Cowen & Co. | → $31 | Initiates Coverage On | → Outperform |
| 03/23/2021 | 713.01% | Stifel | → $30 | Initiates Coverage On | → Buy |
| 02/08/2021 | 848.51% | Aegis Capital | $25 → $35 | Maintains | Buy |
| 08/17/2020 | 577.51% | Aegis Capital | → $25 | Initiates Coverage On | → Buy |
| 06/22/2020 | 171% | ThinkEquity | → $10 | Initiates Coverage On | → Buy |
| 05/13/2020 | 116.8% | Craig-Hallum | $7 → $8 | Maintains | Buy |
| 06/06/2019 | -59.35% | Craig-Hallum | → $1.5 | Initiates Coverage On | → Buy |
What is the target price for DarioHealth (DRIO)?
The latest price target for DarioHealth (NASDAQ: DRIO) was reported by Stifel on July 25, 2023. The analyst firm set a price target for $6.00 expecting DRIO to rise to within 12 months (a possible 62.60% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DarioHealth (DRIO)?
The latest analyst rating for DarioHealth (NASDAQ: DRIO) was provided by Stifel, and DarioHealth maintained their buy rating.
When is the next analyst rating going to be posted or updated for DarioHealth (DRIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DarioHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DarioHealth was filed on July 25, 2023 so you should expect the next rating to be made available sometime around July 25, 2024.
Is the Analyst Rating DarioHealth (DRIO) correct?
While ratings are subjective and will change, the latest DarioHealth (DRIO) rating was a maintained with a price target of $9.00 to $6.00. The current price DarioHealth (DRIO) is trading at is $3.69, which is out of the analyst's predicted range.